Follow
Jolan Harsfalvi, D.Sc.
Jolan Harsfalvi, D.Sc.
Verified email at med.semmelweis-univ.hu
Title
Cited by
Cited by
Year
Factor XIII, clot structure, thrombosis
Z Bagoly, Z Koncz, J Hársfalvi, L Muszbek
Thrombosis research 129 (3), 382-387, 2012
1692012
Antithrombotic effect of platelet glycoprotein Ib–blocking monoclonal antibody Fab fragments in nonhuman primates
N Cauwenberghs, M Meiring, S Vauterin, V van Wyk, S Lamprecht, ...
Arteriosclerosis, thrombosis, and vascular biology 20 (5), 1347-1353, 2000
1652000
Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections
M Papp, Z Vitalis, I Altorjay, I Tornai, M Udvardy, J Harsfalvi, A Vida, ...
Liver International 32 (4), 603-611, 2012
1412012
Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions
J Harsfalvi, JM Stassen, MF Hoylaerts, E Van Houtte, RT Sawyer, ...
1201995
Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibα reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of …
N Cauwenberghs, K Vanhoorelbeke, S Vauterin, DF Westra, G Romo, ...
Blood, The Journal of the American Society of Hematology 98 (3), 652-660, 2001
992001
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease
PL Lakatos, LS Kiss, K Palatka, I Altorjay, P Antal-Szalmas, E Palyu, ...
Inflammatory bowel diseases 17 (3), 767-777, 2011
982011
Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype …
M Papp, I Altorjay, GL Norman, Z Shums, K Palatka, Z Vitalis, I Foldi, ...
Inflammatory bowel diseases 13 (8), 984-992, 2007
922007
Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia
A Molvarec, J Rigó Jr, T Bőze, Z Derzsy, L Cervenak, V Makó, T Gombos, ...
Thrombosis and haemostasis 101 (02), 305-311, 2009
902009
Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis
A Rentka, K Koroskenyi, J Harsfalvi, Z Szekanecz, G Szucs, P Szodoray, ...
Annals of clinical biochemistry 54 (5), 521-529, 2017
852017
Phage display selection of efficient glutamine‐donor substrate peptides for transglutaminase 2
Z Keresztessy, É Csősz, J Hársfalvi, K Csomós, J Gray, RN Lightowlers, ...
Protein science 15 (11), 2466-2480, 2006
712006
Shear-dependent morphology of von Willebrand factor bound to immobilized collagen
L Novák, H Deckmyn, S Damjanovich, J Hársfalvi
Blood, The Journal of the American Society of Hematology 99 (6), 2070-2076, 2002
622002
Factor XIII mediates adhesion of platelets to endothelial cells through αvβ3 and glycoprotein IIb/IIIa integrins
R Dardik, B Shenkman, I Tamarin, R Eskaraev, J Harsfalvi, D Varon, ...
Thrombosis research 105 (4), 317-323, 2002
592002
A novel monoclonal antibody against the extracellular domain of GPIbβ modulates vWF mediated platelet adhesion
C Perrault, S Moog, E Rubinstein, M Santer, MJ Baas, C de la Salle, ...
Thrombosis and haemostasis 86 (11), 1238-1248, 2001
582001
4‐Thio‐deoxyuridylate‐modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix
SM Raviv, A Horvath, J Aradi, Z Bagoly, F Fazakas, Z Batta, L Muszbek, ...
Journal of Thrombosis and Haemostasis 6 (10), 1764-1771, 2008
542008
Enhanced release of IL-6 and IL-8 into tears in various anterior segment eye diseases
M Fodor, A Facskó, É Rajnavölgyi, J Hársfalvi, E Bessenyei, L Kardos, ...
Ophthalmic research 38 (4), 182-188, 2006
542006
Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure
T Gombos, V Makó, L Cervenak, J Papassotiriou, J Kunde, J Hársfalvi, ...
Thrombosis and haemostasis 102 (09), 573-580, 2009
532009
The most severe forms of Perthes’ disease associated with the homozygous Factor V Leiden mutation
K Szepesi, E Posan, J Harsfalvi, E Ajzner, G Szücs, L Gaspar, ...
The Journal of Bone & Joint Surgery British Volume 86 (3), 426-429, 2004
502004
Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure
SJ Henderson, J Xia, H Wu, AR Stafford, BA Leslie, JC Fredenburgh, ...
Thrombosis and haemostasis 115 (03), 533-542, 2016
482016
Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII: C inhibitor
G Pfliegler, Z Boda, J Harsfalvi, M Flora-Nagy, B Sari, K Pecze, K Rak
Postgraduate Medical Journal 65 (764), 400-402, 1989
471989
Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations
M Papp, I Foldi, E Nemes, M Udvardy, J Harsfalvi, I Altorjay, I Mate, ...
Clinical chemistry 54 (4), 697-704, 2008
432008
The system can't perform the operation now. Try again later.
Articles 1–20